| Year |
Citation |
Score |
| 2024 |
Roy Chaudhuri T, Lin Q, Stachowiak EK, Rosario SR, Spernyak JA, Ma WW, Stachowiak MK, Greene MK, Quinn GP, McDade SS, Clynes M, Scott CJ, Straubinger RM. Dual-hit strategy for therapeutic targeting of pancreatic cancer in patient-derived xenograft tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38270582 DOI: 10.1158/1078-0432.CCR-23-0131 |
0.802 |
|
| 2023 |
Lin Q, Serratore A, Perri J, Chaudhuri TR, Qu J, Ma WW, Kandel E, Straubinger RM. FGFR1 expression correlates inversely with the efficacy of single-agent FGFR-specific inhibitors in pancreatic cancer. British Journal of Pharmacology. PMID 37994108 DOI: 10.1111/bph.16289 |
0.786 |
|
| 2023 |
Miao X, Koch G, Shen S, Wang X, Li J, Shen X, Qu J, Straubinger RM, Jusko WJ. Systems Pharmacodynamic Model of Combination Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways. Journal of Pharmaceutical Sciences. PMID 37918792 DOI: 10.1016/j.xphs.2023.10.036 |
0.666 |
|
| 2023 |
Rasam S, Lin Q, Shen S, Straubinger RM, Qu J. Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis Pathway. Journal of Proteome Research. PMID 37906173 DOI: 10.1021/acs.jproteome.3c00463 |
0.816 |
|
| 2023 |
Wang J, Chen T, Ruszaj DM, Mager DE, Straubinger RM. Integrated PK/PD modeling relates Smoothened inhibitor biomarkers to the heterogeneous intratumor disposition of cetuximab in pancreatic cancer tumor models. Journal of Pharmaceutical Sciences. PMID 37844759 DOI: 10.1016/j.xphs.2023.10.019 |
0.626 |
|
| 2023 |
Mager DE, Straubinger RM. Contributions of William Jusko to Development of Pharmacokinetic and Pharmacodynamic Models and Methods. Journal of Pharmaceutical Sciences. PMID 37778439 DOI: 10.1016/j.xphs.2023.09.019 |
0.483 |
|
| 2023 |
Wang X, Niu J, Qian S, Shen S, Straubinger RM, Qu J. Species-Deconvolved Proteomics for Investigation of Tumor-Stroma Interactions after Treatment of Pancreatic Cancer Patient-Derived Xenografts with Combined Gemcitabine and Paclitaxel. Journal of Proteome Research. PMID 37311110 DOI: 10.1021/acs.jproteome.3c00164 |
0.592 |
|
| 2023 |
O'Neill F, Allen-Coyle TJ, Roche S, Meiller J, Conlon NT, Swan N, Straubinger RM, Geoghegan J, Straubinger NL, Conlon K, McDermott R, O'Sullivan F, Henry M, Meleady P, McVey G, et al. Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors. Life (Basel, Switzerland). 13. PMID 36983764 DOI: 10.3390/life13030608 |
0.513 |
|
| 2023 |
Moloney C, Chaudhuri TR, Spernyak JA, Straubinger RM, Brougham DF. Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition. Acta Biomaterialia. PMID 36603732 DOI: 10.1016/j.actbio.2022.12.057 |
0.614 |
|
| 2022 |
Allen-Coyle TJ, Niu J, Welsch E, Conlon NT, Garner W, Clynes M, O'Sullivan F, Straubinger RM, Mager DE, Roche S. FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures. The Aaps Journal. 24: 108. PMID 36229752 DOI: 10.1208/s12248-022-00752-8 |
0.796 |
|
| 2022 |
Lin Q, Shen S, Qian Z, Rasam SS, Serratore A, Jusko WJ, Kandel ES, Qu J, Straubinger RM. Comparative proteomic analysis identifies key metabolic regulators of gemcitabine resistance in pancreatic cancer. Molecular & Cellular Proteomics : McP. 100409. PMID 36084875 DOI: 10.1016/j.mcpro.2022.100409 |
0.795 |
|
| 2022 |
McKiernan EP, Moloney C, Chaudhuri TR, Clerkin S, Behan K, Straubinger RM, Crean J, Brougham DF. Formation of hydrated PEG layers on magnetic iron oxide nanoflowers shows internal magnetisation dynamics and generates high in-vivo efficacy for MRI and magnetic hyperthermia. Acta Biomaterialia. PMID 36007780 DOI: 10.1016/j.actbio.2022.08.033 |
0.607 |
|
| 2022 |
Ghosh S, Sun B, Jahagirdar D, Luo D, Ortega J, Straubinger RM, Lovell JF. Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate. Translational Oncology. 19: 101390. PMID 35290919 DOI: 10.1016/j.tranon.2022.101390 |
0.471 |
|
| 2021 |
Lin Q, Qian Z, Jusko WJ, Mager DE, Ma WW, Straubinger RM. Synergistic pharmacodynamic effects of gemcitabine and fibroblast growth factor receptor inhibitors on pancreatic cancer cell cycle kinetics and proliferation. The Journal of Pharmacology and Experimental Therapeutics. PMID 33753538 DOI: 10.1124/jpet.120.000412 |
0.814 |
|
| 2020 |
Niu J, Wang X, Qu J, Mager DE, Straubinger RM. Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells. Bmc Cancer. 20: 1024. PMID 33097020 DOI: 10.1186/s12885-020-07398-9 |
0.686 |
|
| 2020 |
Greene MK, Chen T, Robinson E, Straubinger NL, Minx C, Chan DKW, Wang J, Burrows JF, Van Schaeybroeck S, Baker JR, Caddick S, Longley DB, Mager DE, Straubinger RM, Chudasama V, et al. Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer. British Journal of Cancer. PMID 32913288 DOI: 10.1038/S41416-020-01046-6 |
0.69 |
|
| 2020 |
Johnston MC, Nicoll JA, Redmond KM, Smyth P, Greene MK, Wj M, Dkw C, Crawford N, Stott KJ, Fox JP, Straubinger NL, Roche S, Clynes M, Straubinger RM, Longley DB, et al. DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32504778 DOI: 10.1016/J.Jconrel.2020.05.046 |
0.708 |
|
| 2020 |
Roche S, O'Neill F, Murphy J, Swan N, Meiller J, Conlon NT, Geoghegan J, Conlon K, McDermott R, Rahman R, Toomey S, Straubinger NL, Straubinger RM, O'Connor R, McVey G, et al. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients. International Journal of Molecular Sciences. 21. PMID 32024004 DOI: 10.3390/Ijms21030962 |
0.609 |
|
| 2019 |
McDaid WJ, Greene MK, Johnston MC, Pollheimer E, Smyth P, McLaughlin K, Van Schaeybroeck S, Straubinger RM, Longley DB, Scott CJ. Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours. Nanoscale. PMID 31626255 DOI: 10.1039/C9Nr07257H |
0.536 |
|
| 2019 |
Wang J, Chan DK, Sen A, Ma WW, Straubinger RM. Tumor priming by SMO inhibition enhances antibody delivery and efficacy in a pancreatic ductal adenocarcinoma model. Molecular Cancer Therapeutics. PMID 31363010 DOI: 10.1158/1535-7163.Mct-18-0354 |
0.747 |
|
| 2019 |
Niu J, Straubinger RM, Mager DE. Pharmacodynamic Drug-Drug Interactions. Clinical Pharmacology and Therapeutics. PMID 30912119 DOI: 10.1002/Cpt.1434 |
0.655 |
|
| 2019 |
Luo D, Carter KA, Molins EAG, Straubinger NL, Geng J, Shao S, Jusko WJ, Straubinger RM, Lovell JF. Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug-light intervals. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30684512 DOI: 10.1016/J.Jconrel.2019.01.030 |
0.655 |
|
| 2019 |
Niu J, Wang X, Shen S, Qu J, Mager D, Straubinger RM. Abstract 3890: Pharmacodynamic and proteomic analysis of combined gemcitabine/nab-paclitaxel in patient-derived pancreatic cancer xenograft models Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3890 |
0.616 |
|
| 2018 |
Ma WW, Xie H, Fetterly G, Pitzonka L, Whitworth A, LeVea C, Wilton J, Mantione K, Schihl S, Dy GK, Boland P, Iyer R, Tan W, Brady W, Straubinger RM, et al. A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. American Journal of Clinical Oncology. PMID 30418178 DOI: 10.1097/Coc.0000000000000492 |
0.674 |
|
| 2018 |
Coleman O, Henry M, O'Neill F, Roche S, Swan N, Boyle L, Murphy J, Meiller J, Conlon NT, Geoghegan J, Conlon KC, Lynch V, Straubinger NL, Straubinger RM, McVey G, et al. A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts. Proteomes. 6. PMID 30404163 DOI: 10.3390/Proteomes6040045 |
0.623 |
|
| 2018 |
Zhu X, Shen X, Qu J, Straubinger RM, Jusko WJ. Multi-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells. Cpt: Pharmacometrics & Systems Pharmacology. PMID 30084546 DOI: 10.1002/psp4.12320 |
0.659 |
|
| 2018 |
Zhu X, Trueman S, Straubinger RM, Jusko WJ. Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xenografts. Journal of Pharmacokinetics and Pharmacodynamics. PMID 30069744 DOI: 10.1007/S10928-018-9603-Z |
0.83 |
|
| 2018 |
Diep JK, Covelli J, Sharma R, Ruszaj DM, Kaye KS, Li J, Straubinger RM, Rao GG. A Comparison of Composition and In Vitro Activity of Polymyxin B Products. International Journal of Antimicrobial Agents. PMID 29807163 DOI: 10.1016/J.Ijantimicag.2018.05.014 |
0.366 |
|
| 2018 |
Camblin AJ, Pace EA, Adams S, Curley MD, Rimkunas V, Nie L, Tan G, Bloom T, Iadevaia S, Baum J, Minx C, Czibere A, Louis CU, Drummond DC, Nielsen UB, ... ... Straubinger RM, et al. Dual inhibition of IGF-1R and ErbB3 enhances the activity of gemcitabine and nab-paclitaxel in preclinical models of pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29549161 DOI: 10.1158/1078-0432.Ccr-17-2262 |
0.644 |
|
| 2018 |
Vaidya T, Straubinger RM, Ait-Oudhia S. Development and Evaluation of Tri-Functional Immunoliposomes for the Treatment of HER2 Positive Breast Cancer. Pharmaceutical Research. 35: 95. PMID 29536232 DOI: 10.1007/S11095-018-2365-X |
0.391 |
|
| 2018 |
Zhu X, Shen X, Qu J, Straubinger RM, Jusko WJ. Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells. Frontiers in Pharmacology. 9: 84. PMID 29520231 DOI: 10.3389/Fphar.2018.00084 |
0.705 |
|
| 2018 |
Wang X, Niu J, Li J, Shen X, Shen S, Straubinger RM, Qu J. Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-scale, Ion-Current-Based Quantitative Proteomics (IonStar). Molecular & Cellular Proteomics : McP. PMID 29358341 DOI: 10.1074/Mcp.Ra117.000519 |
0.628 |
|
| 2018 |
Chan D, Minx C, Wang J, Sen A, Johnston M, Ma WW, Scott CJ, Straubinger RM. Abstract 3704: Efficacy of DR5-targeted immunoliposomes in pancreatic cancer models primed with SMO inhibitors Cancer Research. 78: 3704-3704. DOI: 10.1158/1538-7445.Am2018-3704 |
0.587 |
|
| 2018 |
Sun B, Straubinger RM, Lovell JF. Current taxane formulations and emerging cabazitaxel delivery systems Nano Research. 11: 5193-5218. DOI: 10.1007/S12274-018-2171-0 |
0.479 |
|
| 2017 |
Covelli J, Ruszaj D, Straubinger R, Li J, Rao GG. The development and validation of a simple liquid chromatography-tandem mass spectrometry method for polymyxin B1 and B2 quantification in different matrices. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1065: 112-118. PMID 28961485 DOI: 10.1016/J.Jchromb.2017.09.031 |
0.391 |
|
| 2017 |
Nguyen J, Hossain SS, Cooke JRN, Ellis JA, Deci MB, Emala CW, Bruce JN, Bigio IJ, Straubinger RM, Joshi S. Flow arrest intra-arterial delivery of small TAT-decorated and neutral micelles to gliomas. Journal of Neuro-Oncology. PMID 28421460 DOI: 10.1007/S11060-017-2429-5 |
0.645 |
|
| 2017 |
Gaddy DF, Lee H, Paz N, Leonard SC, Kalra A, Straubinger NL, Straubinger RM, Gillard BM, Moser MT, Foster BA, Drummond DC, Klinz SG, Hendriks B, Fitzgerald JB. Preclinical antitumor activity of nanoliposomal irinotecan (Nal-IRI, MM-398) and utilization as a foundation of front-line pancreatic cancer regimens. Journal of Clinical Oncology. 35: 336-336. DOI: 10.1200/Jco.2017.35.4_Suppl.336 |
0.707 |
|
| 2017 |
Lin Q, Chaudhuri TR, Straubinger NL, Ma WW, Straubinger RM. Abstract 4072: FGFR inhibitors enhance gemcitabine sensitivity in pancreatic ductal adenocarcinoma Cancer Research. 77: 4072-4072. DOI: 10.1158/1538-7445.Am2017-4072 |
0.383 |
|
| 2017 |
Chaudhuri TR, Lin Q, Straubinger NL, Ma WW, Straubinger RM. Abstract 4071: FGFR1 inhibitor reversesSmoothenedinhibition-induced epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma Cancer Research. 77: 4071-4071. DOI: 10.1158/1538-7445.Am2017-4071 |
0.354 |
|
| 2016 |
Tu C, Mojica W, Straubinger RM, Li J, Shen S, Qu M, Nie L, Roberts R, An B, Qu J. Quantitative proteomic profiling of paired cancerous and normal colon epithelial cells isolated freshly from colorectal cancer patients. Proteomics. Clinical Applications. PMID 27943637 DOI: 10.1002/Prca.201600155 |
0.616 |
|
| 2016 |
Miao X, Koch G, Ait-Oudhia S, Straubinger RM, Jusko WJ. Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer Cells. Frontiers in Pharmacology. 7: 421. PMID 27895579 DOI: 10.3389/Fphar.2016.00421 |
0.574 |
|
| 2016 |
Joshi S, Cooke JR, Chan DK, Ellis JA, Hossain SS, Singh-Moon RP, Wang M, Bigio IJ, Bruce JN, Straubinger RM. Liposome size and charge optimization for intraarterial delivery to gliomas. Drug Delivery and Translational Research. PMID 27091339 DOI: 10.1007/S13346-016-0294-Y |
0.775 |
|
| 2016 |
Shen S, Jiang X, Li J, Straubinger RM, Suarez M, Tu C, Duan X, Thompson AC, Qu J. Large-Scale, Ion-Current-Based Proteomic Investigation of the Rat Striatal Proteome in a Model of Short- and Long-Term Cocaine Withdrawal. Journal of Proteome Research. PMID 27018876 DOI: 10.1021/Acs.Jproteome.6B00137 |
0.669 |
|
| 2016 |
Nguyen J, Cooke JR, Ellis JA, Deci M, Emala CW, Bruce JN, Bigio IJ, Straubinger RM, Joshi S. Cationizable lipid micelles as vehicles for intraarterial glioma treatment. Journal of Neuro-Oncology. PMID 26903015 DOI: 10.1007/S11060-016-2088-Y |
0.646 |
|
| 2016 |
Gaddy DF, Lee H, Paz N, Leonard SC, Kalra A, Straubinger NL, Straubinger RM, Gillard BM, Moser MT, Drummond DC, Klinz SG, Hendriks BS, Fitzgerald JB. Abstract 4830: Preclinical anti-tumor activity of nanoliposomal irinotecan (Nal-IRI, MM-398) + 5-FU + oxaliplatin in pancreatic cancer Cancer Research. 76: 4830-4830. DOI: 10.1158/1538-7445.Am2016-4830 |
0.705 |
|
| 2016 |
Drummond DC, Straubinger NL, Chaudhuri TR, Moser M, Kamoun WS, Luus L, Huang ZR, Tipparaju S, Gillard B, Morrison C, Repasky E, Kirpotin DB, Straubinger RM. Abstract 2069: Activity of an EphA2-targeted docetaxel nanoliposome in pancreatic patient-derived models as monotherapy and in combination with gemcitabine Cancer Research. 76: 2069-2069. DOI: 10.1158/1538-7445.Am2016-2069 |
0.706 |
|
| 2015 |
Miao X, Koch G, Straubinger RM, Jusko WJ. Pharmacodynamic modeling of combined chemotherapeutic effects predicts synergistic activity of gemcitabine and trabectedin in pancreatic cancer cells. Cancer Chemotherapy and Pharmacology. PMID 26604207 DOI: 10.1007/S00280-015-2907-4 |
0.566 |
|
| 2015 |
Roy Chaudhuri T, Straubinger NL, Pitoniak RF, Hylander BL, Repasky EA, Ma WW, Straubinger RM. Tumor-priming Smoothened inhibitor enhances deposition and efficacy of cytotoxic nanoparticles in a pancreatic cancer model. Molecular Cancer Therapeutics. PMID 26516158 DOI: 10.1158/1535-7163.Mct-15-0602 |
0.821 |
|
| 2015 |
Zhu X, Straubinger RM, Jusko WJ. Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells. Journal of Pharmacokinetics and Pharmacodynamics. 42: 477-96. PMID 26252969 DOI: 10.1007/S10928-015-9429-X |
0.604 |
|
| 2015 |
Joshi S, Singh-Moon RP, Ellis JA, Chaudhuri DB, Wang M, Reif R, Bruce JN, Bigio IJ, Straubinger RM. Cerebral hypoperfusion-assisted intra-arterial deposition of liposomes in normal and glioma-bearing rats. Neurosurgery. 76: 92-100. PMID 25525695 DOI: 10.1227/Neu.0000000000000552 |
0.611 |
|
| 2014 |
Joshi S, Singh-Moon R, Wang M, Chaudhuri DB, Ellis JA, Bruce JN, Bigio IJ, Straubinger RM. Cationic surface charge enhances early regional deposition of liposomes after intracarotid injection. Journal of Neuro-Oncology. 120: 489-97. PMID 25195130 DOI: 10.1007/S11060-014-1584-1 |
0.645 |
|
| 2014 |
Joshi S, Singh-Moon RP, Wang M, Chaudhuri DB, Holcomb M, Straubinger NL, Bruce JN, Bigio IJ, Straubinger RM. Transient cerebral hypoperfusion assisted intraarterial cationic liposome delivery to brain tissue. Journal of Neuro-Oncology. 118: 73-82. PMID 24664370 DOI: 10.1007/S11060-014-1421-6 |
0.645 |
|
| 2014 |
Ait-Oudhia S, Mager DE, Straubinger RM. Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology. Pharmaceutics. 6: 137-74. PMID 24647104 DOI: 10.3390/Pharmaceutics6010137 |
0.688 |
|
| 2014 |
Zhang H, Hylander BL, LeVea C, Repasky EA, Straubinger RM, Adjei AA, Ma WW. Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models. British Journal of Cancer. 110: 320-9. PMID 24327018 DOI: 10.1038/Bjc.2013.754 |
0.426 |
|
| 2014 |
Wang J, Qu Y, Pitoniak R, Trueman-Fatallah SA, Hylander BL, Repasky EA, Ma WW, Straubinger RM. Abstract 2691: Smo-targeted sonic hedgehog signaling inhibitor enhances therapeutic antibody deposition and efficacy in a patient-derived pancreatic ductal adenocarcinoma model Cancer Research. 74: 2691-2691. DOI: 10.1158/1538-7445.Am2014-2691 |
0.565 |
|
| 2014 |
Kalra AV, Spernyak J, Kim J, Sengooba A, Klinz S, Paz N, Cain J, Kamoun W, Straubinger N, Qu Y, Trueman S, Bayever E, Nielsen U, Drummond D, Fitzgerald J, ... Straubinger R, et al. Abstract 2065: Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI) Cancer Research. 74: 2065-2065. DOI: 10.1158/1538-7445.Am2014-2065 |
0.807 |
|
| 2014 |
Singh-Moon R, Chaudhuri D, Wang M, Straubinger R, Bigio IJ, Joshi S. Multimodal assessment of spatial distribution of drug-tracer uptake by brain tissue after intra-arterial injections Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8951. DOI: 10.1117/12.2040634 |
0.656 |
|
| 2013 |
O'Connell K, Li J, Engler F, Hennessy K, O'Neill F, Straubinger RM, Qu J, O'Connor R. Determination of the Proteomic Response to Lapatinib Treatment using a comprehensive and reproducible ion-current-based proteomics strategy. Journal of Proteomics and Genomics Research. 1: 27-42. PMID 29046878 DOI: 10.14302/issn.2326-0793.jpgr-13-257 |
0.549 |
|
| 2013 |
Hamed SS, Straubinger RM, Jusko WJ. Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells. Cancer Chemotherapy and Pharmacology. 72: 553-63. PMID 23835677 DOI: 10.1007/S00280-013-2226-6 |
0.557 |
|
| 2013 |
Pawaskar DK, Straubinger RM, Fetterly GJ, Hylander BH, Repasky EA, Ma WW, Jusko WJ. Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice. Cancer Chemotherapy and Pharmacology. 71: 1231-40. PMID 23455452 DOI: 10.1007/S00280-013-2117-X |
0.769 |
|
| 2013 |
Pawaskar DK, Straubinger RM, Fetterly GJ, Hylander BH, Repasky EA, Ma WW, Jusko WJ. Physiologically based pharmacokinetic models for everolimus and sorafenib in mice. Cancer Chemotherapy and Pharmacology. 71: 1219-29. PMID 23455451 DOI: 10.1007/S00280-013-2116-Y |
0.752 |
|
| 2013 |
Pawaskar DK, Straubinger RM, Fetterly GJ, Ma WW, Jusko WJ. Interactions of everolimus and sorafenib in whole blood lymphocyte proliferation. Pharmaceutical Research. 30: 707-13. PMID 23151723 DOI: 10.1007/S11095-012-0909-Z |
0.722 |
|
| 2013 |
Ait-Oudhia S, Straubinger RM, Mager DE. Systems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacy. The Journal of Pharmacology and Experimental Therapeutics. 344: 103-12. PMID 23115220 DOI: 10.1124/Jpet.112.199109 |
0.685 |
|
| 2013 |
Pawaskar DK, Straubinger RM, Fetterly GJ, Ma WW, Jusko WJ. Interactions of everolimus and sorafenib in pancreatic cancer cells. The Aaps Journal. 15: 78-84. PMID 23054975 DOI: 10.1208/S12248-012-9417-7 |
0.736 |
|
| 2012 |
Roy Chaudhuri T, Arnold RD, Yang J, Turowski SG, Qu Y, Spernyak JA, Mazurchuk R, Mager DE, Straubinger RM. Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation. Pharmaceutical Research. 29: 3312-24. PMID 22798260 DOI: 10.1007/S11095-012-0823-4 |
0.781 |
|
| 2012 |
Ait-Oudhia S, Straubinger RM, Mager DE. Meta-analysis of nanoparticulate paclitaxel delivery system pharmacokinetics and model prediction of associated neutropenia. Pharmaceutical Research. 29: 2833-44. PMID 22588463 DOI: 10.1007/S11095-012-0775-8 |
0.601 |
|
| 2012 |
Trummer BJ, Iyer V, Balu-Iyer SV, O'Connor R, Straubinger RM. Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinib. Journal of Pharmaceutical Sciences. 101: 2763-76. PMID 22581704 DOI: 10.1002/Jps.23180 |
0.8 |
|
| 2012 |
Harrold JM, Straubinger RM, Mager DE. Combinatorial chemotherapeutic efficacy in non-Hodgkin lymphoma can be predicted by a signaling model of CD20 pharmacodynamics. Cancer Research. 72: 1632-41. PMID 22350416 DOI: 10.1158/0008-5472.Can-11-2432 |
0.65 |
|
| 2012 |
Gaitonde P, Peng A, Straubinger RM, Bankert RB, Balu-Iyer SV. Downregulation of CD40 signal and induction of TGF-β by phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIII. Journal of Pharmaceutical Sciences. 101: 48-55. PMID 21953409 DOI: 10.1002/Jps.22746 |
0.766 |
|
| 2012 |
Chaudhuri TR, Straubinger NL, Pitoniak R, Hylander BL, Jusko WJ, Ma WW, Straubinger RM. Abstract 5685: Effects of sonic Hedgehog inhibitor combined with nanoparticulate drug delivery on vascular permeability and efficacy in a pancreatic cancer model Cancer Research. 72: 5685-5685. DOI: 10.1158/1538-7445.Am2012-5685 |
0.656 |
|
| 2012 |
Ait-Oudhia S, Straubinger RM, Mager DE. Abstract 3980: Computational analysis of paclitaxel-induced tumor priming that leads to enhanced deposition and efficacy nanoparticulate doxorubicin Cancer Research. 72: 3980-3980. DOI: 10.1158/1538-7445.Am2012-3980 |
0.634 |
|
| 2012 |
Pawaskar DK, Straubinger RM, Fetterly G, Hylander BH, Repasky EA, Ma WW, Jusko WJ. Abstract 3681: Multi-scale analysis of everolimus and sorafenib combination in pancreatic cancer xenografts Cancer Research. 72: 3681-3681. DOI: 10.1158/1538-7445.Am2012-3681 |
0.772 |
|
| 2012 |
Zhang H, Hylander B, LeVea C, Repasky E, Straubinger R, Adjei A, Ma WW. Abstract 1214: Effects of dovitinib on fibroblast growth factor receptor-2 (FGFR2) expressing pancreatic cancer Cancer Research. 72: 1214-1214. DOI: 10.1158/1538-7445.Am2012-1214 |
0.499 |
|
| 2012 |
Ma W, Weekes C, Pawaskar D, Fetterly G, Messersmith W, Dy G, Straubinger R, Jusko W, Eckhardt S, Adjei A. 584 Preclinical and Clinical Evaluation of the Combination of Sorafenib and Everolimus in Patients with Advanced Solid Tumors European Journal of Cancer. 48: 179. DOI: 10.1016/S0923-7534(20)33076-3 |
0.715 |
|
| 2011 |
Gaitonde P, Peng A, Straubinger RM, Bankert RB, Balu-Iyer SV. Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function. Clinical Immunology (Orlando, Fla.). 138: 135-45. PMID 21094627 DOI: 10.1016/J.Clim.2010.10.006 |
0.768 |
|
| 2011 |
Pawaskar DK, Straubinger R, Fetterly G, Ma W, Jusko W. Abstract 27: Physiologically based pharmacokinetic model for interactions of sorafenib and everolimus in mice Cancer Research. 71: 27-27. DOI: 10.1158/1538-7445.Am2011-27 |
0.758 |
|
| 2010 |
Peng A, Straubinger RM, Balu-Iyer SV. Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice. The Aaps Journal. 12: 473-81. PMID 20517659 DOI: 10.1208/S12248-010-9207-Z |
0.752 |
|
| 2010 |
Cao J, Gonzalez-Covarrubias V, Covarrubias VM, Straubinger RM, Wang H, Duan X, Yu H, Qu J, Blanco JG. A rapid, reproducible, on-the-fly orthogonal array optimization method for targeted protein quantification by LC/MS and its application for accurate and sensitive quantification of carbonyl reductases in human liver. Analytical Chemistry. 82: 2680-9. PMID 20218584 DOI: 10.1021/Ac902314M |
0.58 |
|
| 2010 |
Yang J, Mager DE, Straubinger RM. Comparison of two pharmacodynamic transduction models for the analysis of tumor therapeutic responses in model systems. The Aaps Journal. 12: 1-10. PMID 19902363 DOI: 10.1208/S12248-009-9155-7 |
0.686 |
|
| 2010 |
Zhou R, Mazurchuk RV, Tamburlin JH, Harrold JM, Mager DE, Straubinger RM. Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model. The Journal of Pharmacology and Experimental Therapeutics. 332: 479-88. PMID 19861574 DOI: 10.1124/Jpet.109.160044 |
0.684 |
|
| 2009 |
Duan X, Young R, Straubinger RM, Page B, Cao J, Wang H, Yu H, Canty JM, Qu J. A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome. Journal of Proteome Research. 8: 2838-50. PMID 19290621 DOI: 10.1021/Pr900001T |
0.573 |
|
| 2009 |
Wang H, Straubinger RM, Aletta JM, Cao J, Duan X, Yu H, Qu J. Accurate localization and relative quantification of arginine methylation using nanoflow liquid chromatography coupled to electron transfer dissociation and orbitrap mass spectrometry. Journal of the American Society For Mass Spectrometry. 20: 507-19. PMID 19110445 DOI: 10.1016/J.Jasms.2008.11.008 |
0.552 |
|
| 2008 |
Gaspar JR, Qu J, Straubinger NL, Straubinger RM. Highly selective and sensitive assay for paclitaxel accumulation by tumor cells based on selective solid phase extraction and micro-flow liquid chromatography coupled to mass spectrometry. The Analyst. 133: 1742-8. PMID 19082078 DOI: 10.1039/B806856A |
0.804 |
|
| 2008 |
Yu H, Straubinger RM, Cao J, Wang H, Qu J. Ultra-sensitive quantification of paclitaxel using selective solid-phase extraction in conjunction with reversed-phase capillary liquid chromatography/tandem mass spectrometry. Journal of Chromatography. A. 1210: 160-7. PMID 18834593 DOI: 10.1016/J.Chroma.2008.09.052 |
0.613 |
|
| 2008 |
Ramani K, Purohit V, Miclea R, Gaitonde P, Straubinger RM, Balu-Iyer SV. Passive transfer of polyethylene glycol to liposomal-recombinant human FVIII enhances its efficacy in a murine model for hemophilia A. Journal of Pharmaceutical Sciences. 97: 3753-64. PMID 18300296 DOI: 10.1002/Jps.21266 |
0.778 |
|
| 2008 |
Ramani K, Miclea RD, Purohit VS, Mager DE, Straubinger RM, Balu-Iyer SV. Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A. Journal of Pharmaceutical Sciences. 97: 1386-98. PMID 17705286 DOI: 10.1002/Jps.21102 |
0.782 |
|
| 2007 |
Straubinger RM, Krzyzanski W, Francoforte CM, Qu J. Applications of quantitative pharmacodynamic effect markers in drug target identification and therapy development. Anticancer Research. 27: 1237-46. PMID 17593615 |
0.768 |
|
| 2007 |
Drake EJ, Cao J, Qu J, Shah MB, Straubinger RM, Gulick AM. The 1.8 A crystal structure of PA2412, an MbtH-like protein from the pyoverdine cluster of Pseudomonas aeruginosa. The Journal of Biological Chemistry. 282: 20425-34. PMID 17502378 DOI: 10.1074/Jbc.M611833200 |
0.544 |
|
| 2007 |
Qu J, Qu Y, Straubinger RM. Ultra-sensitive quantification of corticosteroids in plasma samples using selective solid-phase extraction and reversed-phase capillary high-performance liquid chromatography/tandem mass spectrometry. Analytical Chemistry. 79: 3786-93. PMID 17411010 DOI: 10.1021/Ac062184R |
0.612 |
|
| 2006 |
Qu J, Jusko WJ, Straubinger RM. Utility of cleavable isotope-coded affinity-tagged reagents for quantification of low-copy proteins induced by methylprednisolone using liquid chromatography/tandem mass spectrometry. Analytical Chemistry. 78: 4543-52. PMID 16808464 DOI: 10.1021/Ac0521697 |
0.659 |
|
| 2005 |
Arnold RD, Mager DE, Slack JE, Straubinger RM. Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8856-65. PMID 16361575 DOI: 10.1158/1078-0432.Ccr-05-1365 |
0.804 |
|
| 2005 |
Qu J, Straubinger RM. Improved sensitivity for quantification of proteins using triply charged cleavable isotope-coded affinity tag peptides. Rapid Communications in Mass Spectrometry : Rcm. 19: 2857-64. PMID 16155978 DOI: 10.1002/Rcm.2138 |
0.559 |
|
| 2005 |
Straubinger RM, Balasubramanian SV. Preparation and characterization of taxane-containing liposomes. Methods in Enzymology. 391: 97-117. PMID 15721376 DOI: 10.1016/S0076-6879(05)91005-7 |
0.514 |
|
| 2004 |
Arnold RD, Slack JE, Straubinger RM. Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 808: 141-52. PMID 15261807 DOI: 10.1016/J.Jchromb.2004.04.030 |
0.783 |
|
| 2004 |
Straubinger RM, Arnold RD, Zhou R, Mazurchuk R, Slack JE. Antivascular and antitumor activities of liposome-associated drugs. Anticancer Research. 24: 397-404. PMID 15152936 |
0.818 |
|
| 2003 |
Fetterly GJ, Straubinger RM. Pharmacokinetics of paclitaxel-containing liposomes in rats. Aaps Pharmsci. 5: E32. PMID 15198520 DOI: 10.1208/Ps050432 |
0.66 |
|
| 2002 |
Almon RR, DuBois DC, Brandenburg EH, Shi W, Zhang S, Straubinger RM, Jusko WJ. Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis. Journal of Pharmacokinetics and Pharmacodynamics. 29: 103-29. PMID 12361239 DOI: 10.1023/A:1019762323576 |
0.525 |
|
| 2002 |
Lorenz SA, Bigwarfe PM, Balasubramanian SV, Fetterly GJ, Straubinger RM, Wood TD. Noncovalent dimerization of paclitaxel in solution: evidence from electrospray ionization mass spectrometry. Journal of Pharmaceutical Sciences. 91: 2057-66. PMID 12210052 DOI: 10.1002/Jps.10194 |
0.645 |
|
| 2002 |
Zhou R, Mazurchuk R, Straubinger RM. Antivasculature effects of doxorubicin-containing liposomes in an intracranial rat brain tumor model. Cancer Research. 62: 2561-6. PMID 11980650 |
0.529 |
|
| 2002 |
Balasubramanian SV, Campbell RB, Straubinger RM. Propofol, a general anesthetic, promotes the formation of fluid phase domains in model membranes. Chemistry and Physics of Lipids. 114: 35-44. PMID 11841824 DOI: 10.1016/S0009-3084(01)00199-2 |
0.583 |
|
| 2001 |
Fetterly GJ, Tamburlin JM, Straubinger RM. Paclitaxel pharmacodynamics: application of a mechanism-based neutropenia model. Biopharmaceutics & Drug Disposition. 22: 251-61. PMID 11754041 DOI: 10.1002/Bdd.283 |
0.648 |
|
| 2001 |
Campbell RB, Balasubramanian SV, Straubinger RM. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes. Journal of Pharmaceutical Sciences. 90: 1091-105. PMID 11536214 DOI: 10.1002/Jps.1063 |
0.628 |
|
| 2001 |
Campbell RB, Balasubramanian SV, Straubinger RM. Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties. Biochimica Et Biophysica Acta. 1512: 27-39. PMID 11334622 DOI: 10.1016/S0005-2736(01)00290-5 |
0.621 |
|
| 2000 |
Balasubramanian SV, Bruenn J, Straubinger RM. Liposomes as formulation excipients for protein pharmaceuticals: A model protein study Pharmaceutical Research. 17: 344-350. PMID 10801224 DOI: 10.1023/A:1007561308498 |
0.364 |
|
| 1999 |
Zhou R, Balasubramanian SV, Kahl SB, Straubinger RM. Biopharmaceutics of boronated radiosensitizers: Liposomal formulation of MnBOPP (manganese chelate of 2,4-(α,β-dihydroxyethyl) deuterioporphyrin IX) and comparative toxicity in mice Journal of Pharmaceutical Sciences. 88: 912-917. PMID 10479353 DOI: 10.1021/Js980454I |
0.595 |
|
| 1999 |
Mazurchuk R, Zhou R, Straubinger RM, Chau RI, Grossman Z. Functional magnetic resonance (fMR) imaging of a rat brain tumor model: Implications for evaluation of tumor microvasculature and therapeutic response Magnetic Resonance Imaging. 17: 537-548. PMID 10231180 DOI: 10.1016/S0730-725X(98)00208-2 |
0.564 |
|
| 1998 |
Edgerton M, Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM, Raj PA. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. The Journal of Biological Chemistry. 273: 20438-47. PMID 9685398 DOI: 10.1074/Jbc.273.32.20438 |
0.606 |
|
| 1997 |
Oh YK, Straubinger RM. Cellular retention of liposome-delivered anionic compounds modulated by a probenecid-sensitive anion transporter Pharmaceutical Research. 14: 1203-1209. PMID 9327449 DOI: 10.1023/A:1012158924547 |
0.612 |
|
| 1997 |
Sharma US, Sharma A, Chau RI, Straubinger RM. Liposome-mediated therapy of intracranial brain tumors in a rat model Pharmaceutical Research. 14: 992-998. PMID 9279878 DOI: 10.1023/A:1012136925030 |
0.798 |
|
| 1997 |
Balasubramanian SV, Straubinger RM, Morris ME. Salicylic acid induces changes in the physical properties of model and native kidney membranes Journal of Pharmaceutical Sciences. 86: 199-204. PMID 9040095 DOI: 10.1021/Js9602756 |
0.363 |
|
| 1997 |
Oh YK, Straubinger RM. Impact of Mycobacterium avium infection on macrophage-liposome interaction Journal of Liposome Research. 7: 101-114. DOI: 10.3109/08982109709035488 |
0.384 |
|
| 1996 |
Sharma A, Sharma US, Straubinger RM. Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia Cancer Letters. 107: 265-272. PMID 8947523 DOI: 10.1016/0304-3835(96)04380-7 |
0.787 |
|
| 1996 |
Oh YK, Straubinger RM. Intracellular fate of Mycobacterium avium: Use of dual-label spectrofluorometry to investigate the influence of bacterial viability opsonization on phagosomal pH phagosome-lysosome interaction Infection and Immunity. 64: 319-325. PMID 8557358 DOI: 10.1128/Iai.64.1.319-325.1996 |
0.341 |
|
| 1995 |
Sharma US, Balasubbamanian SV, Straubinger RM. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins Journal of Pharmaceutical Sciences. 84: 1223-1230. PMID 8801338 DOI: 10.1002/Jps.2600841015 |
0.665 |
|
| 1995 |
Sharma A, Straubinger RM, Ojima I, Bernacki RJ. Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice Journal of Pharmaceutical Sciences. 84: 1400-1404. PMID 8748320 DOI: 10.1002/Jps.2600841204 |
0.714 |
|
| 1995 |
Oh YK, Nix DE, Straubinger RM. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection Antimicrobial Agents and Chemotherapy. 39: 2104-2111. PMID 8540724 DOI: 10.1128/Aac.39.9.2104 |
0.45 |
|
| 1995 |
Lee MJ, Straubinger RM, Jusko WJ. Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Tacrolimus (FK 506) in Rats Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 12: 1055-1059. PMID 7494802 DOI: 10.1023/A:1016222817860 |
0.701 |
|
| 1994 |
Sharma A, Straubinger RM. Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing Liposomes Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 11: 889-896. PMID 7937531 DOI: 10.1023/A:1018994111594 |
0.721 |
|
| 1994 |
Sharma A, Conway WD, Straubinger RM. Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma Journal of Chromatography B: Biomedical Sciences and Applications. 655: 315-319. PMID 7915939 DOI: 10.1016/0378-4347(94)00117-0 |
0.663 |
|
| 1994 |
Balasubramanian SV, Straubinger RM. Taxol-lipid interactions: Taxol-dependent effects on the physical properties of model membranes Biochemistry. 33: 8941-8947. PMID 7913831 DOI: 10.1021/Bi00196A011 |
0.437 |
|
| 1994 |
Balasubramanian SV, Alderfer JL, Straubinger RM. Solvent- and concentration-dependent molecular interactions of taxol (Paclitaxel) Journal of Pharmaceutical Sciences. 83: 1470-1476. PMID 7884672 DOI: 10.1002/Jps.2600831021 |
0.456 |
|
| 1994 |
Chau R, Bisson MA, Siegel A, Elkin G, Klim P, Straubinger RM. Distribution of charasomes in Chara: Re-establishment and loss in darkness and correlation with banding and inorganic carbon uptake Australian Journal of Plant Physiology. 21: 113-123. DOI: 10.1071/Pp9940113 |
0.34 |
|
| 1993 |
Huang LR, Straubinger RM, Kahl SB, Koo MS, Alletto JJ, Mazurchuk R, Chau RI, Thamer SL, Fiel RJ. Boronated metalloporphyrins: a novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy. Journal of Magnetic Resonance Imaging : Jmri. 3: 351-6. PMID 8448397 DOI: 10.1002/Jmri.1880030210 |
0.484 |
|
| 1993 |
Straubinger RM. pH-Sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells Methods in Enzymology. 221: 361-376. PMID 8361384 DOI: 10.1016/0076-6879(93)21030-C |
0.393 |
|
| 1993 |
Sharma A, Straubinger NL, Straubinger RM. Modulation of Human Ovarian Tumor Cell Sensitivity to N-(Phosphonacetyl)-L-Aspartate (PALA) by Liposome Drug Carriers Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 10: 1434-1441. PMID 8272404 DOI: 10.1023/A:1018963006703 |
0.74 |
|
| 1993 |
Mishina EV, Straubinger RM, Pyszczynski NA, Jusko WJ. Enhancement of Tissue Delivery and Receptor Occupancy of Methylprednisolone in Rats by a Liposomal Formulation Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 10: 1402-1410. PMID 8272400 DOI: 10.1023/A:1018954704886 |
0.554 |
|
| 1993 |
Straubinger RM, Sharma A, Murray M, Mayhew E. Novel Taxol formulations: Taxol-containing liposomes Journal of the National Cancer Institute. Monographs. 69-78. PMID 7912532 |
0.452 |
|
| 1993 |
Sharma A, Mayhew E, Straubinger RM. Antitumor Effect of Taxol-containing Liposomes in a Taxol-resistant Murine Tumor Model Cancer Research. 53: 5877-5881. PMID 7903197 |
0.403 |
|
| 1990 |
Straubinger RM, Papahadjopoulos D, Hong K. Endocytosis and intracellular fate of liposomes using pyranine as a probe Biochemistry. 29: 4929-4939. PMID 2163672 DOI: 10.1021/Bi00472A025 |
0.581 |
|
| 1990 |
Chin DJ, Green GA, Zon G, Szoka FC, Straubinger RM. Rapid nuclear accumulation of injected oligodeoxyribonucleotides New Biologist. 2: 1091-1100. PMID 1708281 |
0.528 |
|
| 1989 |
Matthay KK, Abai AM, Cobb S, Hong K, Papahadjopoulos D, Straubinger RM. Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells. Cancer Research. 49: 4879-86. PMID 2788031 |
0.353 |
|
| 1989 |
Chin DJ, Straubinger RM, Acton S, Nathke I, Brodsky FM. 100-kDa polypeptides in peripheral clathrin-coated vesicles are required for receptor-mediated endocytosis Proceedings of the National Academy of Sciences of the United States of America. 86: 9289-9293. PMID 2574457 DOI: 10.1073/Pnas.86.23.9289 |
0.365 |
|
| 1988 |
Straubinger RM, Lopez NG, Debs RJ, Hong K, Papahadjopoulos D. Liposome-based Therapy of Human Ovarian Cancer: Parameters Determining Potency of Negatively Charged and Antibody-targeted Liposomes Cancer Research. 48: 5237-5245. PMID 3409248 |
0.472 |
|
| 1988 |
Gabizon A, Hliberty J, Straubinger RM, Price DC, Papahadjopoulos D. An improved method for in vivo tracing and imaging of liposomes using a gallium 67-deferoxamine complex Journal of Liposome Research. 1: 123-135. DOI: 10.3109/08982108809035986 |
0.583 |
|
| 1987 |
Debs RJ, Straubinger RM, Brunette EN, Lin JM, Lin EJ, Montgomery AB, Friend DS, Papahadjopoulos DP. Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes American Review of Respiratory Disease. 135: 731-737. PMID 3826898 |
0.342 |
|
| 1987 |
Debs RJ, Blumenfeld W, Brunette EN, Straubinger RM, Montgomery AB, Lin E, Agabian N, Papahadjopoulos D. Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrobial Agents and Chemotherapy. 31: 37-41. PMID 3494424 DOI: 10.1128/Aac.31.1.37 |
0.634 |
|
| 1985 |
Düzgüneş N, Straubinger RM, Baldwin PA, Friend DS, Papahadjopoulos D. Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes Biochemistry. 24: 3091-3098. PMID 4027231 DOI: 10.1021/Bi00334A004 |
0.575 |
|
| 1985 |
Straubinger RM, Düzgünes N, Papahadjopoulos D. pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules Febs Letters. 179: 148-154. PMID 2578112 DOI: 10.1016/0014-5793(85)80210-6 |
0.583 |
|
| 1983 |
Straubinger RM, Hong K, Friend DS, Papahadjopoulos D. Endocytosis of liposomes and intracellular fate of encapsulated molecules: Encounter with a low pH compartment after internalization in coated vesicles Cell. 32: 1069-1079. PMID 6404557 DOI: 10.1016/0092-8674(83)90291-X |
0.571 |
|
| 1983 |
Straubinger RM, Papahadjopoulos D. Liposomes as carriers for intracellular delivery of nucleic acids Methods in Enzymology. 512-527. PMID 6193396 DOI: 10.1016/0076-6879(83)01035-6 |
0.581 |
|
| 1981 |
Fraley R, Straubinger RM, Rule G, Springer EL, Papahadjopoulos D. Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. Biochemistry. 20: 6978-87. PMID 6274382 DOI: 10.1021/bi00527a031 |
0.728 |
|
| Show low-probability matches. |